Opinion|Videos|July 29, 2024
Identifying Patients Eligible for RSV Vaccine
Experts from clinical and payer backgrounds discuss how patients eligible for the RSV vaccine can be identified.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- How have eligible patients for the RSV vaccine been identified in pharmacies and health systems? Have RSV vaccines become annual immunizations like flu vaccines?
- Have electronic health records been built to identify eligible patients and incorporate RSV vaccines immunization records? How has the identification of eligible patients been implemented into workflow?
- From a payer perspective, how have you ensured eligible patients are identified for immunization?
- From a payer perspective, how have you ensured eligible patients are identified for immunization?
Advertisement
Related to this article
Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
A retrospective study suggests strength exercise may be a safer option than endurance exercise for some people with ACM.
Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, diffuse-type disease.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
The pilot pairs grocery stipends and community health worker support with members who have unmanaged diabetes and unmet social needs.
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
3
Pulmonary Embolism Can Affect Elite Athletes, Too: Samantha Pettigrew, MD
4
Uninsured Rate Rises to 11.2% as Coverage Erodes Before Medicaid Cuts
5